Myocardial infarction in a low risk patient with hereditary hemorrhagic telangiectasia

Cardiology Journal

Volumn 17, Issue 2, 2010, Pages 189-191

  Janion, Marianna ^a,b   Brzyzkiewicz, Halina ^a   Siuda, Marcin ^a   Domagała, Szymon ^a   Karliński, Michał ^c  

^a wietokrzyskie Cardiology Centre Regional District Hospital Department of Cardiac Surgery   (Poland)

^b JAN KOCHANOWSKI UNIVERSITY   (Poland)

^c INSTITUTE OF PSYCHIATRY AND NEUROLOGY   (Poland)

Author keywords

Acute coronary syndrome; Anemia; Hereditary hemorrhagic telangiectasia

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; FOLIC ACID; HEMOGLOBIN; IRON; METOPROLOL; PERINDOPRIL; SIMVASTATIN; TROPONIN; ANTITHROMBOCYTIC AGENT;

ACUTE CORONARY SYNDROME; ADULT; ANEMIA; ANGIOCARDIOGRAPHY; ANGIOMA; ARTICLE; BRAIN ARTERY ANEURYSM; CARDIOVASCULAR RISK; CASE REPORT; CORONARY ARTERY BYPASS GRAFT; DISEASE COURSE; DISEASE DURATION; ELECTROCARDIOGRAPHY; EPISTAXIS; ERYTHROCYTE TRANSFUSION; FEMALE; HEART INFARCTION; HEMATOCRIT; HUMAN; LABORATORY TEST; MEAN CORPUSCULAR VOLUME; NUCLEAR MAGNETIC RESONANCE IMAGING; PHYSICAL EXAMINATION; RENDU OSLER WEBER DISEASE; ST SEGMENT DEPRESSION; TREATMENT RESPONSE; BLOOD; COMPLICATION; MAGNETIC RESONANCE ANGIOGRAPHY; MIDDLE AGED; MYOCARDIAL INFARCTION; RISK ASSESSMENT; RISK FACTOR; TELANGIECTASIA, HEREDITARY HEMORRHAGIC; TREATMENT OUTCOME;

ACUTE CORONARY SYNDROME; ANEMIA; CORONARY ANGIOGRAPHY; CORONARY ARTERY BYPASS; EPISTAXIS; FEMALE; HUMANS; MAGNETIC RESONANCE ANGIOGRAPHY; MIDDLE AGED; MYOCARDIAL INFARCTION; PLATELET AGGREGATION INHIBITORS; RISK ASSESSMENT; RISK FACTORS; TELANGIECTASIA, HEREDITARY HEMORRHAGIC; TREATMENT OUTCOME;

EID: 77951161293     PISSN: 18975593     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Perry WH. Clinical spectrum of hereditary hemorrhagic telangiectasia (Osler-Weber-Rendu disease). Am J Med, 1987; 82: 989-997.
2. Guttmacher AE, Marchuk DA, White RI. Hereditary hemorrhagic telangiectasia. N Engl J Med, 1995; 333: 918-924.
3. Sabba C, Pasculli G, Suppressa P et al. Life expectancy in patients with hereditary haemorrhagic telangiectasia. QJM, 2006; 99: 327-334.
4. Plauchu H, de Chadarevian JP, Bideau A, Robert JM. Age-related clinical profile of hereditary hemorrhagic telangiectasia in an epidemiologically recruited population. Am J Med Genet, 1989; 32: 291-297.
5. Zucker DR, Griffith JL, Beshansky JR, Selker HP. Presentations of acute myocardial infarction in men and women. J Gen Intern Med, 1997; 12: 132-134.
6. Manfroi WC, Peukert C, Berti CB, Noer C, de Ávila Gutierres D, da Silva FTBGC. Acute myocardial infarction. The first manifestation of ischemic heart disease and relation to risk factors. Arq Bras Cardiol, 2002; 78: 392-395.
7. Pierard LA, Dubois C, Smeets JP, Boland J, Carlier J, Kulbertus HE. Prognostic significance of angina pectoris before first acute myocardial infarction. Am J Cardiol, 1988; 61: 984-987.
8. Matsuda Y, Ogawa H, Moritani K et al. Effects of the presence or absence of preceding angina pectoris on left ventricular function after acute myocardial infarction. Am Heart J, 1984; 108: 955-958.
9. Sabatine MS, Morrow DA, Giugliano RP et al. Association of hemoglobin levels with clinical outcomes in acute coronary syndromes. Circulation, 2005; 111: 2042-2049.
10. Yang X, Alexander KP, Chen AY et al. The implications of blood transfusions for patients with non-ST segment elevation acute coronary syndromes results from the CRUSADE National Quality Improvement Initiative. J Am Coll Cardiol, 2005; 46: 1490-1495.
11. Gallitelli M, Pasculli G, Fiore T, Carella A, Sabba C. Emergencies in hereditary haemorrhagic telangiectasia. Q J Med, 2006; 99: 15-22.
12. Talha S, Brandt C, Maamari G, Mossard J-M, Germain P, Andres E. Myocardial infarction in a patient with normal coronary arteries and hereditary haemorrhagic telangiectasia. Q J Med, 2006; 99: 195-198.
13. Welch HG, Meehan KR, Goodnough L. Prudent strategies for elective red blood cell transfusion. Ann Intern Med, 1992; 116: 393-402.